Italia markets close in 5 hours 24 minutes

Mithra Pharmaceuticals SA (0R91.IL)

IOB - IOB Prezzo differito. Valuta in EUR.
Aggiungi a watchlist
0,2215+0,0000 (+0,00%)
In data: 05:11PM BST. Mercato aperto.
Schermo intero
Chiusura precedente0,2215
Aperto0,0000
Denaro0,2060 x 0
Lettera0,2360 x 0
Min-Max giorno0,2215 - 0,2215
Intervallo di 52 settimane0,2040 - 3,8500
Volume39
Media Volume14.822
Capitalizzazione18,629M
Beta (5 anni mensile)0,73
Rapporto PE (ttm)N/D
EPS (ttm)-1,4100
Prossima data utiliN/D
Rendimento e dividendo (futuro)N/D (N/D)
Data ex dividendoN/D
Stima target 1AN/D
  • GlobeNewswire

    Shareholder Letter

    Dear Shareholders, We write to you today with a deep sense of responsibility and transparency, driven by our commitment to the principles of sound corporate governance and the long-term success of Mithra. We believe it is our duty to address recent developments concerning the request of some shareholders for the upcoming Special General Meeting of Shareholders ("SGM") to be held on October 30, 2023. The SGM will be followed by an Extraordinary Meeting of Shareholders ("EGM"). The main topics of

  • GlobeNewswire

    Mithra announces update to the agenda of its upcoming special general shareholders’ meeting

    Liege, Belgium, 11 October 2023 – 7:00 CEST – Mithra (Euronext Brussels: MITRA) (the "Company"), a company dedicated to Women’s Health, today announces that it has received a request, in accordance with article 7:130 of the Belgian Companies and Associations Code, from a group of shareholders holding together more than 3% of the Company's outstanding shares to add additional items and resolutions to the agenda of its special general shareholders’ meeting ("SGM") that will be held on Monday, Octo

  • GlobeNewswire

    Mithra to Hold Presentations on Key Role of Estrogens in Women’s Health, Including Estetrol (E4), at FIGO World Congress

    Mithra to hold joint symposium with partner Gedeon Richter on 11 OctoberFour leading experts will outline why estrogens are critical in contraception and postmenopausal symptomsData show promising safety and efficacy features of E4, key ingredient in ESTELLE® and DONESTA® Liege, Belgium, 10 October 2023 – 18:00 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, will hold four presentations on the role of estrogens - including its Estetrol (E4) - in a symposium at th